;PMID: 11698137
;source_file_2926.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:48..124] = [t:48..124]
;2)section:[e:128..179] = [t:128..179]
;3)section:[e:183..285] = [t:183..285]
;4)sentence:[e:289..479] = [t:289..479]
;5)sentence:[e:480..613] = [t:480..613]
;6)sentence:[e:614..688] = [t:614..688]
;7)sentence:[e:689..789] = [t:689..789]
;8)sentence:[e:790..1001] = [t:790..1001]
;9)sentence:[e:1002..1154] = [t:1002..1154]
;10)sentence:[e:1156..1299] = [t:1156..1299]
;11)sentence:[e:1300..1429] = [t:1300..1429]
;12)section:[e:1433..1478] = [t:1433..1478]

;section 0 Span:0..42
;Neurosci Lett.  2001 Nov 13;314(1-2):21-4.
(SEC
  (FRAG (NNP:[0..8] Neurosci) (NNP:[9..13] Lett) (.:[13..14] .)
        (CD:[16..20] 2001) (NNP:[21..24] Nov) (CD:[25..27] 13) (::[27..28] ;)
        (CD:[28..31] 314) (-LRB-:[31..32] -LRB-) (CD:[32..35] 1-2)
        (-RRB-:[35..36] -RRB-) (::[36..37] :) (CD:[37..41] 21-4) (.:[41..42] .)))

;sentence 1 Span:48..124
;Characterization of the 5'-sequence of the mouse fatty acid amide hydrolase.
;[97..123]:gene-protein:"fatty acid amide hydrolase"
(SENT
  (NP-HLN
    (NP (NN:[48..64] Characterization))
    (PP (IN:[65..67] of)
      (NP
        (NP (DT:[68..71] the)
          (NML (CD:[72..73] 5) (SYM:[73..74] '))
          (HYPH:[74..75] -) (NN:[75..83] sequence))
        (PP (IN:[84..86] of)
          (NP (DT:[87..90] the) (NN:[91..96] mouse)
             (JJ:[97..102] fatty) (NN:[103..107] acid) (NN:[108..113] amide)
             (NN:[114..123] hydrolase)))))
    (.:[123..124] .)))

;section 2 Span:128..179
;Puffenbarger RA, Kapulina O, Howell JM, Deutsch DG.
(SEC
  (FRAG (NNP:[128..140] Puffenbarger) (NNP:[141..143] RA) (,:[143..144] ,)
        (NNP:[145..153] Kapulina) (NNP:[154..155] O) (,:[155..156] ,)
        (NNP:[157..163] Howell) (NNP:[164..166] JM) (,:[166..167] ,)
        (NNP:[168..175] Deutsch) (NNP:[176..179] DG.)))

;section 3 Span:183..285
;Department of Biology, Bridgewater College, 402 East College Street, 
;Bridgewater, VA 22812-1599, USA.
(SEC
  (FRAG (NNP:[183..193] Department) (IN:[194..196] of) (NNP:[197..204] Biology)
        (,:[204..205] ,) (NNP:[206..217] Bridgewater) (NNP:[218..225] College)
        (,:[225..226] ,) (CD:[227..230] 402) (NNP:[231..235] East)
        (NNP:[236..243] College) (NNP:[244..250] Street) (,:[250..251] ,)
        (NNP:[253..264] Bridgewater) (,:[264..265] ,) (NNP:[266..268] VA)
        (CD:[269..279] 22812-1599) (,:[279..280] ,) (NNP:[281..284] USA)
        (.:[284..285] .)))

;sentence 4 Span:289..479
;Fatty acid amide hydrolase (FAAH) is critical for degradation of several 
;important fatty acid amides including anandamide, an endocannabinoid, as well
;as  oleamide, a sleep-inducing factor.
;[289..315]:gene-protein:"Fatty acid amide hydrolase"
;[317..321]:gene-protein:"FAAH"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[289..294] Fatty) (NN:[295..299] acid) (NN:[300..305] amide)
          (NN:[306..315] hydrolase))
      (NP (-LRB-:[316..317] -LRB-) (NN:[317..321] FAAH) (-RRB-:[321..322] -RRB-)))
    (VP (VBZ:[323..325] is)
      (ADJP-PRD (JJ:[326..334] critical)
        (PP (IN:[335..338] for)
          (NP
            (NP (NN:[339..350] degradation))
            (PP (IN:[351..353] of)
              (NP
                (NP (JJ:[354..361] several) (JJ:[363..372] important)
                    (JJ:[373..378] fatty) (NN:[379..383] acid)
                    (NNS:[384..390] amides))
                (PP (VBG:[391..400] including)
                  (NP
                    (NP
                      (NP (NN:[401..411] anandamide))
                      (,:[411..412] ,)
                      (NP (DT:[413..415] an) (NN:[416..431] endocannabinoid)))
                    (,:[431..432] ,)
                    (CONJP (RB:[433..435] as) (RB:[436..440] well)
                           (IN:[441..443] as))
                    (NP
                      (NP (NN:[445..453] oleamide))
                      (,:[453..454] ,)
                      (NP (DT:[455..456] a)
                        (ADJP (NN:[457..462] sleep) (HYPH:[462..463] -)
                              (VBG:[463..471] inducing))
                        (NN:[472..478] factor)))))))))))
    (.:[478..479] .)))

;sentence 5 Span:480..613
;These compounds play roles in diverse  physiological processes ranging from
;memory and learning to the regulation of  blood pressure.
(SENT
  (S
    (NP-SBJ (DT:[480..485] These) (NNS:[486..495] compounds))
    (VP (VBP:[496..500] play)
      (NP (NNS:[501..506] roles))
      (PP (IN:[507..509] in)
        (NP
          (NP (JJ:[510..517] diverse) (JJ:[519..532] physiological)
              (NNS:[533..542] processes))
          (VP (VBG:[543..550] ranging)
            (PP (IN:[551..555] from)
              (NP (NN:[556..562] memory) (CC:[563..566] and)
                  (NN:[567..575] learning)))
            (PP (TO:[576..578] to)
              (NP
                (NP (DT:[579..582] the) (NN:[583..593] regulation))
                (PP (IN:[594..596] of)
                  (NP (NN:[598..603] blood) (NN:[604..612] pressure)))))))))
    (.:[612..613] .)))

;sentence 6 Span:614..688
;The mechanisms that regulate FAAH expression have not been  characterized.
;[643..647]:gene-protein:"FAAH"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[614..617] The) (NNS:[618..628] mechanisms))
      (SBAR
        (WHNP-2 (WDT:[629..633] that))
        (S
          (NP-SBJ-2 (-NONE-:[633..633] *T*))
          (VP (VBP:[634..642] regulate)
            (NP (NN:[643..647] FAAH) (NN:[648..658] expression))))))
    (VP (VBP:[659..663] have) (RB:[664..667] not)
      (VP (VBN:[668..672] been)
        (VP (VBN:[674..687] characterized)
          (NP-1 (-NONE-:[687..687] *)))))
    (.:[687..688] .)))

;sentence 7 Span:689..789
;A 5'-region of the mouse FAAH with promoter activity was isolated  from 1.8
;kbp of genomic sequence.
;[714..718]:gene-rna:"FAAH"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[689..690] A)
        (NML (CD:[691..692] 5) (SYM:[692..693] '))
        (HYPH:[693..694] -) (NN:[694..700] region))
      (PP (IN:[701..703] of)
        (NP
          (NP (DT:[704..707] the) (NN:[708..713] mouse) (NN:[714..718] FAAH))
          (PP (IN:[719..723] with)
            (NP (NN:[724..732] promoter) (NN:[733..741] activity))))))
    (VP (VBD:[742..745] was)
      (VP (VBN:[746..754] isolated)
        (NP-1 (-NONE-:[754..754] *))
        (PP (IN:[756..760] from)
          (NP
            (NP (CD:[761..764] 1.8) (NN:[765..768] kbp))
            (PP (IN:[769..771] of)
              (NP (JJ:[772..779] genomic) (NN:[780..788] sequence)))))))
    (.:[788..789] .)))

;sentence 8 Span:790..1001
;Characterization of +1 of transcription of  FAAH by RNA ligase mediated-rapid
;amplification of cDNA ends showed that FAAH  mRNA is transcribed from
;multiple transcription start sites lacking a TATA-box  element.
;[834..838]:gene-rna:"FAAH"
;[842..852]:gene-protein:"RNA ligase"
;[907..911]:gene-rna:"FAAH"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[790..806] Characterization))
      (PP (IN:[807..809] of)
        (NP
          (NP (SYM:[810..811] +) (CD:[811..812] 1))
          (PP (IN:[813..815] of)
            (NP
              (NP (NN:[816..829] transcription))
              (PP (IN:[830..832] of)
                (NP (NN:[834..838] FAAH)))))))
      (PP (IN:[839..841] by)
        (NP
          (NP
            (ADJP
              (NML (NN:[842..845] RNA) (NN:[846..852] ligase))
              (VBN:[853..861] mediated))
            (HYPH:[861..862] -) (JJ:[862..867] rapid)
             (NN:[868..881] amplification))
          (PP (IN:[882..884] of)
            (NP (NN:[885..889] cDNA) (NNS:[890..894] ends))))))
    (VP (VBD:[895..901] showed)
      (SBAR (IN:[902..906] that)
        (S
          (NP-SBJ-1 (NN:[907..911] FAAH) (NN:[913..917] mRNA))
          (VP (VBZ:[918..920] is)
            (VP (VBN:[921..932] transcribed)
              (NP-1 (-NONE-:[932..932] *))
              (PP (IN:[933..937] from)
                (NP
                  (NP (JJ:[938..946] multiple) (NN:[947..960] transcription)
                      (NN:[961..966] start) (NNS:[967..972] sites))
                  (VP (VBG:[973..980] lacking)
                    (NP (DT:[981..982] a)
                      (ADJP (NN:[983..987] TATA) (HYPH:[987..988] -)
                            (NN:[988..991] box))
                      (NN:[993..1000] element))))))))))
    (.:[1000..1001] .)))

;sentence 9 Span:1002..1154
;Functional analysis of the FAAH upstream sequence fused to a luciferase 
;reporter gene revealed a FAAH-promoter construct with tissue specific
;activity.
;[1029..1033]:gene-rna:"FAAH"
;[1063..1083]:gene-rna:"luciferase  reporter"
;[1100..1104]:gene-rna:"FAAH"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[1002..1012] Functional) (NN:[1013..1021] analysis))
      (PP (IN:[1022..1024] of)
        (NP
          (NP (DT:[1025..1028] the) (NN:[1029..1033] FAAH)
              (JJ:[1034..1042] upstream) (NN:[1043..1051] sequence))
          (VP (VBN:[1052..1057] fused)
            (PP (TO:[1058..1060] to)
              (NP (DT:[1061..1062] a)
                 (NN:[1063..1073] luciferase) (NN:[1075..1083] reporter)
                (NN:[1084..1088] gene)))))))
    (VP (VBD:[1089..1097] revealed)
      (NP (DT:[1098..1099] a)
        (NML (NN:[1100..1104] FAAH) (HYPH:[1104..1105] -)
             (NN:[1105..1113] promoter))
        (NN:[1114..1123] construct))
      (PP (IN:[1124..1128] with)
        (NP
          (ADJP (NN:[1129..1135] tissue) (JJ:[1136..1144] specific))
          (NN:[1145..1153] activity))))
    (.:[1153..1154] .)))

;sentence 10 Span:1156..1299
;A 674-bp FAAH-promoter construct was active in N18TG2 (N18) neuroblastoma
;cells  and C6 glioma cells, lines that have endogenous FAAH activity.
;[1165..1169]:gene-rna:"FAAH"
;[1216..1229]:malignancy-type:"neuroblastoma"
;[1244..1250]:malignancy-type:"glioma"
;[1285..1289]:gene-protein:"FAAH"
(SENT
  (S
    (NP-SBJ (DT:[1156..1157] A)
      (NML (CD:[1158..1161] 674) (HYPH:[1161..1162] -) (NN:[1162..1164] bp))
      (NML (NN:[1165..1169] FAAH) (HYPH:[1169..1170] -)
           (NN:[1170..1178] promoter))
      (NN:[1179..1188] construct))
    (VP (VBD:[1189..1192] was)
      (ADJP-PRD (JJ:[1193..1199] active))
      (PP (IN:[1200..1202] in)
        (NP
          (NP
            (NP
              (NML
                (NML (NN:[1203..1209] N18TG2))
                (NML (-LRB-:[1210..1211] -LRB-) (NN:[1211..1214] N18)
                     (-RRB-:[1214..1215] -RRB-)))
              (NN:[1216..1229] neuroblastoma) (NNS:[1230..1235] cells))
            (CC:[1237..1240] and)
            (NP (NN:[1241..1243] C6) (NN:[1244..1250] glioma)
                (NNS:[1251..1256] cells)))
          (,:[1256..1257] ,)
          (NP
            (NP (NNS:[1258..1263] lines))
            (SBAR
              (WHNP-1 (WDT:[1264..1268] that))
              (S
                (NP-SBJ-1 (-NONE-:[1268..1268] *T*))
                (VP (VBP:[1269..1273] have)
                  (NP (JJ:[1274..1284] endogenous) (NN:[1285..1289] FAAH)
                      (NN:[1290..1298] activity)))))))))
    (.:[1298..1299] .)))

;sentence 11 Span:1300..1429
;The same 674-bp  FAAH-promoter construct was not active in C2C12 or L6
;myogenic cells, two lines  that do not have FAAH activity.
;[1317..1321]:gene-rna:"FAAH"
;[1415..1419]:gene-protein:"FAAH"
(SENT
  (S
    (NP-SBJ (DT:[1300..1303] The) (JJ:[1304..1308] same)
      (NML (CD:[1309..1312] 674) (HYPH:[1312..1313] -) (NN:[1313..1315] bp))
      (NML (NN:[1317..1321] FAAH) (HYPH:[1321..1322] -)
           (NN:[1322..1330] promoter))
      (NN:[1331..1340] construct))
    (VP (VBD:[1341..1344] was) (RB:[1345..1348] not)
      (ADJP-PRD (JJ:[1349..1355] active))
      (PP (IN:[1356..1358] in)
        (NP
          (NP
            (NP (NN:[1359..1364] C2C12)
              (NML-1 (-NONE-:[1364..1364] *P*)))
            (CC:[1365..1367] or)
            (NP (NN:[1368..1370] L6)
              (NML-1 (JJ:[1371..1379] myogenic) (NNS:[1380..1385] cells))))
          (,:[1385..1386] ,)
          (NP
            (NP (CD:[1387..1390] two) (NNS:[1391..1396] lines))
            (SBAR
              (WHNP-2 (WDT:[1398..1402] that))
              (S
                (NP-SBJ-2 (-NONE-:[1402..1402] *T*))
                (VP (VBP:[1403..1405] do) (RB:[1406..1409] not)
                  (VP (VB:[1410..1414] have)
                    (NP (NN:[1415..1419] FAAH) (NN:[1420..1428] activity))))))))))
    (.:[1428..1429] .)))

;section 12 Span:1433..1478
;PMID: 11698137 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1433..1437] PMID) (::[1437..1438] :) (CD:[1439..1447] 11698137)
        (NN:[1448..1449] -LSB-) (NNP:[1449..1455] PubMed) (::[1456..1457] -)
        (NN:[1458..1465] indexed) (IN:[1466..1469] for)
        (NNP:[1470..1477] MEDLINE) (-RRB-:[1477..1478] -RSB-)))
